The pharmaceutical drug delivery market is expected to reach US$ 2,296,170.9 Mn in 2027 from US$ 1,403,082.9 Mn in 2019. The market is estimated to grow at a CAGR of 6.6% during 2020–2027.
Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular.
Lucrative Regional Markets for Pharmaceutical Drug Delivery
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Prevalence of Infectious and Chronic Diseases
The prevalence of infectious disease, especially bacterial diseases, is increasing continuously around the globe. According to a study published by American Society for Microbiology in 2019, the world reports ~1.5–4.5 million infections are caused by Carbapenem-resistant Enterobacteriaceae every year. Additionally, this group of bacteria also leads to the hospitalization of ~49,000 people in the US each year. Moreover, according to a study published by UNICEF, in 2018, pneumonia caused ~1,755,000 deaths of children with age <5; also, ~1,200,000 children in the word lost their lives by diarrhea. Such exponentially growing prevalence of infectious diseases drives the consumption of drugs, which eventually drives the pharmaceutical drug delivery market growth.
Among chronic conditions, cancer and diabetes are the leading cause of mortality worldwide. For instance, according to a study conducted by the American Cancer Society (ACS), the US reported ~1,735,350 new cancer cases in 2018. Further, according to the International Diabetes Federation (IDF), ~46 million Americans were suffering from diabetes in 2017, and this number is expected to reach 62 million by 2045. It has also mentioned that ~425 million people worldwide were living with diabetes in 2017, and the number is expected to reach 629 million by 2045.
Route of Administration Insights
The pharmaceutical drug delivery market, by route of administration, is segmented into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. The injectable drug delivery segment held the largest share of the market in 2019. However, the topical drug delivery segment is anticipated to register the highest CAGR in the market during the forecast period.
Pharmaceutical Drug Delivery Market, by Route of Administration – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Applications Insights
On the basis of applications, the pharmaceutical drug delivery market has been segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other diseases. The cancer segment held the largest share of the market in 2019; however, the infectious diseases segment is estimated to register the highest CAGR during the forecast period.
End User Insights
On the basis of end user, the pharmaceutical drug delivery market has been segmented into hospitals, home care settings, ASC/clinics, and other end users. The hospitals segment held the largest share of the market in 2019, whereas the home care settings segment is estimated to register the highest CAGR during 2020–2027.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmaceutical Drug Delivery Market: Strategic Insights
Market Size Value in US$ 1,403,082.9 Million in 2019 Market Size Value by US$ 2,296,170.9 Million by 2027 Growth rate CAGR of 6.6% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pharmaceutical Drug Delivery Market: Strategic Insights
| Market Size Value in | US$ 1,403,082.9 Million in 2019 |
| Market Size Value by | US$ 2,296,170.9 Million by 2027 |
| Growth rate | CAGR of 6.6% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product launches and approvals is commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players to expand their corresponding product portfolios.
The players operating in the pharmaceutical drug delivery market adopt the strategy of expansion to enlarge customer base across the world; they also implement the strategies of collaborations and product launches. These strategies permit them to maintain their brand name globally. For instance, in May 2018, GlaxoSmithKline plc received an FDA approval for the use of Arnuity Ellipta (fluticasone furoate) for the maintenance treatment of asthma in children below 5 years. It is a once-daily inhaled corticosteroid (ICS) medicine.
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Geography
North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
Asia Pacific (APAC)
- China
- India
- Japan
- South Korea
- Australia
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
South and Central America (SCAM)
- Brazil
- Argentina
Company Profiles
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services, Inc.
- Novartis AG
- 3M
- Becton, Dickinson and Company
- Sanofi
- Merck KGaA
- GlaxoSmithKline plc.
- Antares Pharma
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Route of Administration ; Application ; End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.
The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.
The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmaceutical Drug Delivery Market – By Route of Administration
1.3.2 Global Pharmaceutical Drug Delivery Market – By Application
1.3.3 Global Pharmaceutical Drug Delivery Market – By End User
1.3.4 Global Pharmaceutical Drug Delivery Market – By Geography
2. Pharmaceutical Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Pharmaceutical Drug Delivery Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion
5. Pharmaceutical Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Infectious and Chronic Diseases
5.1.2 Increasing R&D Spending for Drug Delivery Devices
5.2 Market Restraints
5.2.1 High Cost of Drug Delivery Device Development
5.3 Market Opportunities
5.3.1 Increasing Patient Compliance
5.4 Future Trends
5.4.1 Growth in Drug Delivery Technology and Innovations
5.5 Impact Analysis
6. Pharmaceutical Drug Delivery Market – Global Analysis
6.1 Global Pharmaceutical Drug Delivery Market Revenue Forecast And Analysis
6.2 Global Pharmaceutical Drug Delivery Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Pharmaceutical Drug Delivery Market Analysis – By Route of Administration
7.1 Overview
7.2 Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
7.3 Oral Drug Delivery
7.3.1 Overview
7.3.2 Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Injectable Drug Delivery
7.4.1 Overview
7.4.2 Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Ocular Drug Delivery
7.6.1 Overview
7.6.2 Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Pulmonary Drug Delivery
7.7.1 Overview
7.7.2 Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Nasal Drug Delivery
7.8.1 Overview
7.8.2 Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Transmucosal Drug Delivery
7.9.1 Overview
7.9.2 Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.10 Implantable Drug Delivery
7.10.1 Overview
7.10.2 Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Drug Delivery Market Analysis – By Application
8.1 Overview
8.2 Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Cancer
8.4.1 Overview
8.4.2 Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Cardiovascular Diseases
8.5.1 Overview
8.5.2 Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Diabetes
8.6.1 Overview
8.6.2 Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Respiratory Diseases
8.7.1 Overview
8.7.2 Respiratory Diseases : Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Central Nervous System Disorders
8.8.1 Overview
8.8.2 Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.9 Autoimmune Diseases
8.9.1 Overview
8.9.2 Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.10 Other Diseases
8.10.1 Overview
8.10.2 Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Pharmaceutical Drug Delivery Market Analysis – By End User
9.1 Overview
9.2 Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 ASCs/ Clinics
9.5.1 Overview
9.5.2 ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Other End Users
9.6.1 Overview
9.6.2 Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Pharmaceutical Drug Delivery Market – Geographic Analysis
10.1 North America: Pharmaceutical Drug Delivery Market
10.1.1 Overview
10.1.2 North America: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 US: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Pharmaceutical Drug Delivery Market
10.2.1 Overview
10.2.2 Europe: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Pharmaceutical Drug Delivery Market
10.3.1 Overview
10.3.2 Asia Pacific: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia Pacific Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
10.3.7 China: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Pharmaceutical Drug Delivery Market
10.4.1 Overview
10.4.2 Middle East & Africa: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Pharmaceutical Drug Delivery Market, by Country, 2018 & 2027 (%)
10.4.7 Saudi Arabia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Pharmaceutical Drug Delivery Market
10.5.1 Overview
10.5.2 South and Central America: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of World: Impact Assessment of COVID-19 Pandemic
12. Pharmaceutical Drug Delivery Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in The Pharmaceutical Drug Delivery Market, 2016-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 3M
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Antares Pharma
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bayer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 GlaxoSmithKline plc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MERCK KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Pfizer Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novartis AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Johnson & Johnson Services, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pharmaceutical Drug Delivery Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Pharmaceutical Drug Delivery Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. US Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. US Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. US Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. UK Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 20. UK Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 21. UK Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 22. France Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 23. France Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 24. France Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 25. Spain Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia Pacific Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. China Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 35. China Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 36. China Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 37. Japan Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 40. India Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 41. India Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 42. India Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 43. South Korea Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 46. Australia Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 49. Middle East & Africa Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East & Africa Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East & Africa Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 52. Saudi Arabia Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 55. UAE Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 58. South Africa Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 61. South and Central America Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 64. Brazil Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 67. Argentina Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 70. Recent Inorganic Growth Strategies In The Pharmaceutical Drug Delivery Market
Table 71. Recent Organic Growth Strategies In The Pharmaceutical Drug Delivery Market
Table 72. Glossary of Terms, Pharmaceutical Drug Delivery Market
LIST OF FIGURES
Figure 1. Pharmaceutical Drug Delivery Market Segmentation
Figure 2. Pharmaceutical Drug Delivery Segmentation, By Region
Figure 3. Pharmaceutical Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery Segment Held Largest Share of Pharmaceutical Drug Delivery Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Pharmaceutical Drug Delivery Market, by Geography (US$ Million)
Figure 7. Global Pharmaceutical Drug Delivery Market – Leading Country Markets (US$ Million)
Figure 8. Global Pharmaceutical Drug Delivery Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Pharmaceutical Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 15. Global Pharmaceutical Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Pharmaceutical Drug Delivery Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Pharmaceutical Drug Delivery Market
Figure 18. Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 19. Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
Figure 28. Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 35. Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 36. Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027 (%)
Figure 37. Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 38. Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 39. ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 40. Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 41. North America: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 42. North America Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 43. North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 44. US: Pharmaceutical Drug Delivery market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Europe: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 48. Europe Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 49. Europe: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 50. Germany: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. UK: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. France: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Spain: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Italy: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Asia Pacific: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 56. Asia Pacific Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 57. Asia Pacific: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 58. China: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. Japan: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. India: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. South Korea: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. Australia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Middle East & Africa: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 64. Middle East & Africa Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 65. Middle East & Africa: Pharmaceutical Drug Delivery Market, by Country, 2018 & 2027 (%)
Figure 66. Saudi Arabia: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 67. UAE: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. South Africa: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. South and Central America: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)
Figure 70. South and Central America Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 71. South and Central America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 72. Brazil: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 73. Argentina: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
Figure 74. Impact of COVID-19 Pandemic in North American Country Markets
Figure 75. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 76. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 77. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 78. Growth Strategies in the Pharmaceutical Drug Delivery Market, 2016-2020
The List of Companies - Pharmaceutical Drug Delivery Market
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services, Inc.
- Novartis AG
- 3M
- Becton, Dickinson and Company
- Sanofi
- MERCK KGaA
- GlaxoSmithKline plc.
- Antares Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pharmaceutical Drug Delivery Market
May 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)